
Robert Edward Fuller
Examiner (ID: 9118)
| Most Active Art Unit | 3676 |
| Art Unit(s) | 3676, 3672 |
| Total Applications | 1115 |
| Issued Applications | 825 |
| Pending Applications | 108 |
| Abandoned Applications | 205 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7061799
[patent_doc_number] => 20050004161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => '4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents'
[patent_app_type] => utility
[patent_app_number] => 10/881960
[patent_app_country] => US
[patent_app_date] => 2004-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20693
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20050004161.pdf
[firstpage_image] =>[orig_patent_app_number] => 10881960
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/881960 | 4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents | Jun 28, 2004 | Abandoned |
Array
(
[id] => 682786
[patent_doc_number] => 07081531
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-25
[patent_title] => 'Bridged bicyclic amine derivatives useful as CCR-3 receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/787921
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11893
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/081/07081531.pdf
[firstpage_image] =>[orig_patent_app_number] => 10787921
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/787921 | Bridged bicyclic amine derivatives useful as CCR-3 receptor antagonists | Feb 25, 2004 | Issued |
Array
(
[id] => 716126
[patent_doc_number] => 07053107
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-30
[patent_title] => 'Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use'
[patent_app_type] => utility
[patent_app_number] => 10/737655
[patent_app_country] => US
[patent_app_date] => 2003-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34125
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/053/07053107.pdf
[firstpage_image] =>[orig_patent_app_number] => 10737655
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/737655 | Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use | Dec 14, 2003 | Issued |
Array
(
[id] => 7238564
[patent_doc_number] => 20040157804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Pre-organized tricyclic integrase inhibitor compounds'
[patent_app_type] => new
[patent_app_number] => 10/687374
[patent_app_country] => US
[patent_app_date] => 2003-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 90996
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20040157804.pdf
[firstpage_image] =>[orig_patent_app_number] => 10687374
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/687374 | Pre-organized tricyclic integrase inhibitor compounds | Oct 14, 2003 | Abandoned |
Array
(
[id] => 782832
[patent_doc_number] => 06992080
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-01-31
[patent_title] => 'Imidazopyridines as cyclin dependent kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/664338
[patent_app_country] => US
[patent_app_date] => 2003-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12636
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/992/06992080.pdf
[firstpage_image] =>[orig_patent_app_number] => 10664338
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/664338 | Imidazopyridines as cyclin dependent kinase inhibitors | Sep 16, 2003 | Issued |
Array
(
[id] => 7291338
[patent_doc_number] => 20040110787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Heteroaryl-ethanolamine derivatives as antiviral agents'
[patent_app_type] => new
[patent_app_number] => 10/649301
[patent_app_country] => US
[patent_app_date] => 2003-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27204
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110787.pdf
[firstpage_image] =>[orig_patent_app_number] => 10649301
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/649301 | Heteroaryl-ethanolamine derivatives as antiviral agents | Aug 26, 2003 | Abandoned |
Array
(
[id] => 6809606
[patent_doc_number] => 20030199545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'New esters of hydroxyl-substituted nitrogen heterocycles, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions'
[patent_app_type] => new
[patent_app_number] => 10/396147
[patent_app_country] => US
[patent_app_date] => 2003-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10404
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20030199545.pdf
[firstpage_image] =>[orig_patent_app_number] => 10396147
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/396147 | Esters of hydroxyl-substituted nitrogen heterocycles, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions | Mar 24, 2003 | Issued |
Array
(
[id] => 695441
[patent_doc_number] => 07071207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-04
[patent_title] => 'Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity'
[patent_app_type] => utility
[patent_app_number] => 10/487976
[patent_app_country] => US
[patent_app_date] => 2002-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24431
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/071/07071207.pdf
[firstpage_image] =>[orig_patent_app_number] => 10487976
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487976 | Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity | Sep 23, 2002 | Issued |
Array
(
[id] => 758187
[patent_doc_number] => 07015231
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-21
[patent_title] => 'Chemical compounds'
[patent_app_type] => utility
[patent_app_number] => 10/490831
[patent_app_country] => US
[patent_app_date] => 2002-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10241
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/015/07015231.pdf
[firstpage_image] =>[orig_patent_app_number] => 10490831
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/490831 | Chemical compounds | Sep 23, 2002 | Issued |
Array
(
[id] => 6640851
[patent_doc_number] => 20030212140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Novel thiourea compounds and the pharmaceutical compositions containing the same'
[patent_app_type] => new
[patent_app_number] => 10/362079
[patent_app_country] => US
[patent_app_date] => 2003-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8492
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20030212140.pdf
[firstpage_image] =>[orig_patent_app_number] => 10362079
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/362079 | Thiourea compounds and the pharmaceutical compositions containing the same | Aug 19, 2001 | Issued |